Cumulus cell microRNA expression when LH is added to the ovarian stimulation protocol: a pilot study

被引:3
作者
Vigo, Francieli Maria [1 ]
Fraietta, Renato [2 ]
Rodrigues, Fernanda [1 ,3 ]
Carvalho, Cristina, V [1 ]
Bonetti, Tatiana C. S. [1 ]
Motta, Eduardo L. A. [1 ,3 ]
机构
[1] Univ Fed Sao Paulo, Dept Ginecol, Escola Paulista Med, UNIFESP EPM, Rua Napoleao Barros,608 Vila Clementino, BR-04024002 Sao Paulo, SP, Brazil
[2] Univ Fed Sao Paulo, Setor Integrad Reprod Humana, UNIFESP EPM, Escola Paulista Med,Dept Cirurgia, Rua Botucatu,725 Vila Vila Clementino, BR-04024002 Sao Paulo, SP, Brazil
[3] Huntington Med Reprod, Av Republ Libano 529 Ibirapuera, BR-04501000 Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
MicroRNA; Ovarian stimulation; PCR array; Recombinant LH; GRANULOSA-CELLS; OOCYTE; FERTILIZATION; MATURATION; HORMONE; MIRNAS; IVF;
D O I
10.1016/j.rbmo.2021.07.014
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Research question: Recombinant FSH administration in ovarian stimulation for IVF is a standard procedure, whereas the role of LH is controversial. MicroRNAs (mRNA) are small endogenous non-coding transcripts that are involved in the regulation of many cellular processes, including foliculogenesis and gonadotrophin function. The aim was to study the possible role of miRNA in ovarian follicular development in groups having different ovarian stimulation protocols. Are there different miRNA expression profiles in cumulus cells of infertile women undergoing IVF? What are the regulated pathways? Design: This prospective observational study included 13 patients who fulfilled the following inclusion criteria: younger than 38 years of age; a tubal infertility factor; a male factor; or idiopathic infertility. This is a pilot study in which the patients were aleatory enrolled into two groups: seven in FSH group (recombinant FSH, 225 IU) and six in FSH plus LH group (recombinant FSH, 150 IU + recombinant LH, 75 IU). The granulosa cells obtained from the follicular ovarian retrieval were analysed using polyerase chain reaction. Results were analysed using DIANA Tools, an online bioinformatics tool. Results: Among the 84 microRNAs evaluated, 11 were differentially expressed between the groups, all of which were upregulated in the FSH plus LH group, compared with the FSH group. Differentially expressed miRNA profiles are related to oestrogen signalling, oocyte meiosis and pluripotent cells regulation. Conclusion: miRNA overexpression in the FSH plus LH group is consistent with the independent and fundamental role of LH in folliculogenesis, leading to a distinct molecular response between groups.
引用
收藏
页码:1070 / 1077
页数:8
相关论文
共 50 条
  • [31] A study of meiotic segregation in a fertile human population following ovarian stimulation with recombinant FSH-LH
    Velilla, Esther
    Fernandez, Silvia F.
    Sunol, Jordi
    Lopez-Teijon, Marisa
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2013, 30 (02) : 269 - 274
  • [32] Expression and regulatory effects of microRNA-182 in osteosarcoma cells: A pilot study
    Bian, Dong-Lin
    Wang, Xue-Mei
    Huang, Kun
    Zhai, Qi-Xi
    Yu, Gui-Bo
    Wu, Cheng-Hua
    ONCOLOGY LETTERS, 2016, 11 (05) : 3040 - 3048
  • [33] Micronized natural progesterone (Seidigestan®) vs GnRH antagonists for preventing the LH surge during controlled ovarian stimulation (PRO_NAT study): study protocol of a randomized clinical trial
    Martinez-Moya, M.
    Guerrero, J.
    Girela, J. L.
    Pitas, A.
    Bernabeu, A.
    Bernabeu, R.
    Castillo, J. C.
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [34] Serum metabolites as predictive molecular markers of ovarian response to controlled stimulation: a pilot study
    Borges, Edson
    Montani, Daniela Antunes
    Setti, Amanda Souza
    Zanetti, Bianca Ferrarini
    Savio Figueira, Rita de Cassia
    Iaconelli, Assumpto, Jr.
    Oliveira-Silva, Diogo
    de Almeida Ferreira Braga, Daniela Paes
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2019, 23 (04): : 323 - 327
  • [35] B cell translocation gene 2 expression levels in human granulosa cells is negatively associated with in vitro fertilization/intracytoplasmic sperm injection outcomes: a pilot study
    Luo, Jiahuan
    Wang, Huawei
    Zhou, Ling
    Wang, Longda
    Wang, Jinyuan
    Song, Mengjie
    Cheng, Yulin
    Rao, Meng
    Zhao, Shuhua
    Tang, Li
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2025, : 909 - 922
  • [36] Zinc concentrations in serum and follicular fluid during ovarian stimulation and expression of Zn2+ transporters in human oocytes and cumulus cells
    Menezo, Yves
    Pluntz, Laurene
    Chouteau, Jacques
    Gurgan, Timur
    Demirol, Aygul
    Dalleac, Alain
    Benkhalifa, Moncef
    REPRODUCTIVE BIOMEDICINE ONLINE, 2011, 22 (06) : 647 - 652
  • [37] Progestin-primed ovarian stimulation protocol with or without clomiphene citrate for poor ovarian responders: a retrospective cohort study
    Ahui Liu
    Jie Li
    Haofei Shen
    Lili Zhang
    Qiuyuan Li
    Xuehong Zhang
    BMC Women's Health, 22
  • [38] Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study
    Zavesky, Ludek
    Jandakova, Eva
    Turyna, Radovan
    Langmeierova, Lucie
    Weinberger, Vit
    Zaveska Drabkova, Lenka
    Hulkova, Martina
    Horinek, Ales
    Duskova, Daniela
    Feyereisl, Jaroslav
    Minar, Lubos
    Kohoutova, Milada
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (04) : 1027 - 1035
  • [39] The comparison of mild stimulation vs. controlled ovarian hyperstimulation protocol in poor ovarian responders: a prospective randomized study
    Huang, R.
    Wang, B.
    Yang, X.
    Li, T. T.
    Liang, X. Y.
    HUMAN REPRODUCTION, 2015, 30 : 49 - 50
  • [40] Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective Study
    Butler, Alexandra E.
    Ramachandran, Vimal
    Cunningham, Thomas Keith
    David, Rhiannon
    Gooderham, Nigel J.
    Benurwar, Manasi
    Dargham, Soha R.
    Hayat, Shahina
    Sathyapalan, Thozhukat
    Najafi-Shoushtari, S. Hani
    Atkin, Stephen L.
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11